期刊文献+

芦丁脂质纳米混悬剂的制备及性质考察 被引量:3

下载PDF
导出
摘要 目的:制备芦丁脂质纳米混悬剂,以提高芦丁的水溶性,进而提高其生物利用度。方法:采用高压均质法制备芦丁脂质纳米混悬剂,并对所制备的芦丁脂质纳米混悬剂进行体外性质考察。结果:所制备的芦丁脂质纳米混悬剂平均粒径为(198.00±4.15)nm,平均包封率为(41.88±0.98)%,在三种介质中的释放量均超过80%。结论:所制备的芦丁脂质纳米混悬剂包封率、粒径符合要求,能够显著提高芦丁的溶出度。
出处 《中外医学研究》 2015年第8期150-152,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
  • 相关文献

参考文献6

  • 1Chavarria C, Souza J M.Oxidation and nitration of ct -synuclein and their implications in neurodegenerative diseases[J].Arch BiochemBiophys, 2013, 533(1-2): 25-32.
  • 2Indrajit G, Sonali B, Radha V, et al.Nanosuspension for impro- ving the bioavailability of a poor soluble drug and screening of sta-bilizing agents to inhibit crystal growth[J].Int J Pharm, 2011, 409(1-2): 260- 268.
  • 3Shin M S, Lee Y, Kim H, et al.Method for preparing nanoparti-cles comprising vitamin K and poly-isopropyl-butyl metbacry-late-acrylic acid copolymer with supercritical fluid using molecu-lar association theory: US, 20080152715(AI)[P].2008-06-26.
  • 4Mishra P R, A1 Shaal L, MUller R H, et al.Production and char- acterization of hespcretin nanosuspensi0ns for dermal delivery[J].Int J Pharm, 2009, 371(1-2): 182-189.
  • 5严佳栋.芦丁固体脂质纳米粒制剂在大鼠体内的药代动力学研究[J].时珍国医国药,2012,23(11):2907-2908. 被引量:5
  • 6李萌,王芳.高温乳化-低温固化法制备芦丁固体脂质纳米粒及理化性质分析[J].临床误诊误治,2010,23(7):606-608. 被引量:3

二级参考文献20

  • 1毛世瑞,王燕芝,纪宏宇,毕殿洲.微乳化技术制备固体脂质纳米粒[J].药学学报,2003,38(8):624-626. 被引量:38
  • 2秦绿叶,刘爽,汪沉然,王均辉,岳鑫,于常海.巨胞饮的机制及功能的研究进展[J].生理科学进展,2006,37(1):41-44. 被引量:9
  • 3林巧平,郭仁平,许向阳,刘春晖.注射用姜黄素脂质体的制备及其质量评价[J].中国天然药物,2007,5(3):207-210. 被引量:24
  • 4赵守训,黄泰康,丁志遵,等.中药辞海(第3卷)[M].北京:中国医药科技出版社,1997:1443.
  • 5Mehnert W,Mader K.Solid lipid nanoparticles:production,characterization and applications[J].Adv Drug Deliv Rev,2001,47(2-3):165-196.
  • 6Wang F,You J,Sun Y,et al.Studies on PEG-modified SLNs loading vinorelbine bitartrate (I):Preparation and evaluation in vitro[J].Int J Pharm,2008,359(1-2):104-110.
  • 7Venkateswarlu V,Manjunath K.Preparation,characterization and in vitro release kinetics of clozapine solid lipid nanoparticles[J].J Control Release,2004,95(3):627-638.
  • 8Reddy L H,Vivek K,Bakshi N,et al.Tamoxifen citrate loaded solid lipid nanoparticles (SLN):preparation,characterization,in vitro drug release,and pharmacokinetic evaluation[J].Pharm Dev Technol,2006,11(2):167-177.
  • 9Merisko L E,Liversidge G G,Cooper E R.Nanosizing:a formulation approach for poorly-water-soluble compounds[J].Eur J Pharm Sci,2003,18(2):113-120.
  • 10Jacobs C,Kayser O,Muller R H.Production and characterisation of mucoadhesive nanosuspensions for the formulation of bupravaquone[J].Int J Pharm,2001,214(1-2):3-7,10.

共引文献6

同被引文献75

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部